mtDNA mutations, hearing loss and aminoglycoside treatment in Mexicans

G Meza1, N M Torres-Ruíz, C Tirado-Gutiérrez

  • 1División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México. gmeza@ifc.unam.mx

Abstract

Insights

Aminoglycoside antibiotics can cause hearing loss. In Mexicans, a T1189C mitochondrial variant was found in two patients treated with streptomycin, suggesting it may be linked to hypersensitivity.

Area of Science:

  • Genetics
  • Otolaryngology
  • Pharmacology

Background:

  • Streptomycin and aminoglycosides treat tuberculosis but can cause auditory and vestibular dysfunction.
  • Mitochondrial DNA mutations are linked to aminoglycoside hypersensitivity.
  • Mexicans are susceptible to these alterations due to historical overuse of aminoglycosides.

Purpose of the Study:

  • Investigate specific "hot spot" mitochondrial DNA mutations previously linked to inner ear damage.
  • Determine the prevalence of these mutations in a Mexican population undergoing audiological and vestibular testing.

Main Methods:

  • Screened 65 subjects for mutations in the 12S rRNA and tRNA Serine (UCN) genes using PCR-RFLP and sequencing.
  • Conducted audiological and vestibular assessments on all participants.

Main Results:

  • 32 subjects had normal auditory and vestibular function; 33 had auditory impairments.
  • No previously identified mutations for aminoglycoside hypersensitivity or non-syndromic hearing loss were detected.
  • Two hearing-impaired patients treated with streptomycin exhibited the T1189C variant in the mitochondrial 12S rRNA.

Conclusions:

  • Commonly reported mutations for hearing loss in other populations were not found in this Mexican cohort.
  • The T1189C mitochondrial variant is a potential candidate mutation associated with aminoglycoside hypersensitivity in Mexicans.

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair01:36

Mismatch Repair

Overview
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Mutations01:39

Mutations

Overview